Image
Join the MidAtlantic AETC to discuss creative methods to incorporate long-acting injectable ART into clinical workflows by sharing ideas on scheduling, patient education, and follow-up care for patients with HIV.
Objectives
- Discuss dosage and prescribing guidelines for long-acting injectable antiretroviral therapy (ART), including pharmacokinetics, potential side effects, and clinical management plans for patients with HIV.
- Evaluate the criteria for selecting appropriate candidates for long-acting injectable ART, considering factors such as adherence, access, and comorbid conditions.
- Analyze clinical workflows that can be adapted to incorporate long-acting injectable ART into routine care, including scheduling, patient education, and follow-up procedures.
Speaker
Helen Koenig, MD, MPH
Professor of Clinical Medicine, Infectious Diseases
University of Pennsylvania, Perelman School of Medicine
Medical Director, MacGregor Infection Medicine & Travel Clinic
Medical Director, PrEP Program, Philadelphia FIGHT